According to a new study, there is no increased risk of infections in pediatric psoriasis (PsO) patients treated with ustekinumab compared to etanercept or methotrexate.
top of page
it's where dermatology lives
More Publications by © Chronicle Companies
Publishers of: The Chronicle of Skin & Allergy; Skin Spectrum Quarterly;
Women in Dermatology; The Chronicle of Cosmetic Medicine + Surgery
www.chronicle.ca www.derm.city www.skinspectrum.ca
© Chronicle Companies 2023
bottom of page
Commentaires